Assess • Improve • Measure
AIM: Gout Practice Improvement Module Development Group
Audrey Uknis, MD, Chair
Temple University School of Medicine
Philadelphia, PA
M. Anthony Albornoz, MD
Darby, PA
Alan Epstein, MD
Pennsylvania Hospital, Rheumatology
Philadelphia, PA
Steve Magid, MD
Hospital for Special Surgery
New York, NY
Michele Meltzer, MD
Jefferson University
Philadelphia, PA
Julianne Orlowski, DO
Center for Arthritis
Chesapeake, VA
Stuart Schneller, MD
Boston, MA
John RP Tesser, MD
Arizona Arthritis Rheum Assoc
Paradise Valley, AZ
Conflict of Interest / Disclosure Statements
As an educational provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) it is the ACR’s policy to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers’ bureau
- Other
Faculty disclosures listed apply in numeric format according to the list above. In accordance with ACR policy an individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for the development, management, presentation or evaluation of the CME activity.
The faculty reported the following disclosures:
- Audrey B. Uknis, MD, Chair – Biogen-Idec, Roche: 2, 5.
- Alan L. Epstein, MD - Eli Lilly: 2.
- Julianne S. Orlowski, MD – Pfizer: 1.
- Steve Magid, MD – Nothing to disclose.
- Michele Meltzer, MD – Merck: 8
- Stuart J. Schneller, MD – Abbott: 8
- John RP Tesser, MD – Americus: 1; Amgen Inc. and Wyeth Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Glaxo Smith Kline: 8.
